Evidence map›Paper›PMID 33637067›Full record

ArticleBMC medical genomics2021

A hemizygous mutation in the FOXP3 gene (IPEX syndrome) resulting in recurrent X-linked fetal hydrops: a case report.

Panicos Shangaris, Alison Ho, Andreas Marnerides, Simi George, Mudher AlAdnani, Shu Yau, Mattias Jansson, Jacqueline Hoyle, Joo Wook Ahn, Sian Ellard and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Panicos Shangaris *Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, 10th Floor North Wing, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. panicos.shangaris@kcl.ac.uk.ORCID 0000-0003-2750-8405
Alison Ho *Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, 10th Floor North Wing, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Andreas MarneridesDepartment of Histopathology, St Thomas Hospital, Westminster Bridge Road, London, SE17EH, UK.
Simi GeorgeDepartment of Histopathology, St Thomas Hospital, Westminster Bridge Road, London, SE17EH, UK.
Mudher AlAdnaniDepartment of Histopathology, St Thomas Hospital, Westminster Bridge Road, London, SE17EH, UK.
Shu YauDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mattias JanssonDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Jacqueline HoyleDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Joo Wook AhnDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sian EllardDepartment of Molecular Genetics, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK.
Melita IrvingDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Diana WellesleyWessex Clinical Genetics Service, Princess Anne Hospital, Southampton, SO16 5YA, UK.
Dharmintra Pasupathy *Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, 10th Floor North Wing, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Muriel Holder-Espinasse *Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Guy's and St Thomas' NHS Foundation Trust · GBSt Thomas' Hospital · GBPrincess Anne Hospital · GBRoyal Devon and Exeter Hospital · GBThe University of Sydney · AU

Funding

Academy of Medical Sciences SGL023\1023National Institute for Health Research CL-2018-17-002
6 · The paper itself

Abstract

backgroundFetal hydrops is excessive extravasation of fluid into the third space in a fetus, which could be due to a wide differential of underlying pathology. IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome primarily affects males. It is a monogenic primary immunodeficiency syndrome of X-linked recessive inheritance due to FOXP3 gene variants. It is characterised by the development of multiple autoimmune disorders in affected individuals. CASE PRESENTATION: We present a rare cause of male fetal hydrops in the context of IPEX syndrome and discuss FOXP3 gene variants as a differential for 'unexplained' fetal hydrops that may present after the first trimester. DISCUSSION AND

conclusionsIn all similar cases, the pathological process begins during intrauterine life. Furthermore, there are no survivors described. Consequently, this variant should be considered as a severe one, associated with intrauterine life onset and fatal course, i.e., the most severe IPEX phenotype.

Indexed as

Forkhead Transcription FactorsGenetic Diseases, X-LinkedHydrops FetalisAdultDiabetes Mellitus, Type 1DiarrheaFemaleHumansImmune System DiseasesMaleMutationPregnancyForkhead Transcription FactorsFOXP3 protein, humanFetal hydropsFOXP3In utero transfusionIPEX syndrome

Identifiers

PMID33637067
PMCPMC7908803
OpenAlexW3130796895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.